180 Life Sciences Corp. Quarterly report pursuant to Section 13 or 15(d)

Derivative Liabilities (Details) - Schedule of warrants activity	9 Months Ended
	Sep. 30, 2021 USD ($) $ / shares shares
Schedule of warrants activity [Abstract]
Number of Warrants, Beginning balance \| shares	6,001,250
Weighted Average Exercise Price, Beginning balance \| $ / shares	$ 11.5
Number of Warrants, Issued \| shares	5,152,658
Weighted Average Exercise Price, Issued \| $ / shares	$ 6.23
Number of Warrants, Exercised \| shares
Weighted Average Exercise Price, Exercised \| $ / shares
Number of Warrants, Cancelled \| shares
Weighted Average Exercise Price, Cancelled \| $ / shares
Number of Warrants, Expired \| shares
Weighted Average Exercise Price, Expired \| $ / shares
Number of Warrants, Outstanding, \| shares	11,153,908
Weighted Average Exercise Price, Outstanding, \| $ / shares	$ 9.06
Weighted Average Remaining Life in Years, Outstanding,	4 years 3 months 18 days
Intrinsic Value, Outstanding, \| $	$ 1,059,516
Number of Warrants, Exercisable \| shares	11,153,908
Weighted Average Exercise Price, Exercisable \| $ / shares	$ 9.06
Weighted Average Remaining Life in Years. Exercisable	4 years 3 months 18 days
Intrinsic Value, Exercisable \| $	$ 1,059,516